Skip to content

Osborn Williams & Donohoe LLC: CME position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Osborn Williams & Donohoe LLC on CME, newest first. How the timeline and the estimate are built.

Osborn Williams & Donohoe LLC held 17,995 CME shares at 2020-03-31 per its 13F-HR/A filed 2020-05-06.

the latest 13F is the newest step

  1. period ended2020-03-31
    13F/A 17,995 shares
    Change vs previous 13F -625 shares

    0.41% of the 13F portfolio, value $3,112,000.

    13F-HR/A 0001583000-20-000003 filed by Osborn Williams & Donohoe LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2019-12-31
    13F 18,620 shares
    Change vs previous 13F +625 shares

    0.37% of the 13F portfolio, value $3,737,000.

    13F-HR 0001583000-20-000001 filed by Osborn Williams & Donohoe LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2019-09-30
    13F 17,995 shares
    Change vs previous 13F +180 shares

    0.38% of the 13F portfolio, value $3,803,000.

    13F-HR 0001583000-19-000004 filed by Osborn Williams & Donohoe LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2019-06-30
    13F 17,815 shares
    Change vs previous 13F +840 shares

    0.36% of the 13F portfolio, value $3,458,000.

    13F-HR 0001583000-19-000003 filed by Osborn Williams & Donohoe LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2019-03-31
    13F 16,975 shares
    Change vs previous 13F not available

    0.3% of the 13F portfolio, value $2,895,000.

    13F-HR 0001583000-19-000002 filed by Osborn Williams & Donohoe LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).